Zobrazeno 1 - 10
of 244
pro vyhledávání: '"Madit crt"'
CHA 2 DS 2 ‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
Autor:
Valentina Kutyifa, Ilan Goldenberg, Scott McNitt, Roy Beinart, Rosero Spencer, Eyal Nof, David T. Huang, Jeffrey J. Goldberger, Mehmet K. Aktas
Publikováno v:
Journal of the American Heart Association. 9
Background We hypothesized that multiple cardiovascular comorbidities, incorporated in the CHA 2 DS 2 ‐ VAS c score, may be useful in the assessment of ventricular tachyarrhythmias ( VTAs ) and mortality risk in heart failure ( HF ) patients. Metho
Autor:
Yitschak Biton, Valentina Kutyifa, Sana M. Al-Khatib, Wojciech Zareba, James P. Daubert, Scott McNitt, Arthur J. Moss, Scott D. Solomon, Emily P. Zeitler, Daniel J. Friedman
Publikováno v:
Journal of the American College of Cardiology. 69:2369-2379
Background Data regarding cardiac resynchronization therapy (CRT) in patients with multiple comorbidities are limited.
Autor:
Valentina Kutyifa, Jeffrey D. Alexis, Igor Gosev, Scott McNitt, Slava Polonsky, Himabindu Vidula, John D. Bisognano, Sabu Thomas, Ilan Goldenberg
Publikováno v:
Journal of Cardiac Failure. 26:S9-S10
Introduction Little is known about the effects of cardiac resynchronization therapy (CRT-D) on hospitalizations during long-term follow up. We assessed the impact of CRT-D on CV and non-CV hospitalizations in patients randomized to implantable cardio
Publikováno v:
European Heart Journal. 40
Background Data on the risk of life-threatening ventricular tachyarrhythmia events in diabetes patients with mild heart failure (HF) and higher ejection fraction (LVEF) are not currently known. Objective We aimed to assess the risk of life-threatenin
Autor:
László Gellér, B Merkely, Annamaria Kosztin, Valentina Kutyifa, Scott McNitt, Vivien Klaudia Nagy, I. Goldenberg, Scott D. Solomon
Publikováno v:
European Heart Journal. 40
Background Long-term predictive value of baseline right ventricular (RV) function and CRT-induced changes of RV function for the clinical outcomes, mortality or heart failure are not well understood, especially in mild HF patients implanted with CRT-
Autor:
Valentina Kutyifa, I. Goldenberg, Brian Claggett, Mauro Gori, Amil M. Shah, Michele Senni, Scott D. Solomon
Publikováno v:
European Heart Journal. 40
Background Diastolic dysfunction (DD) is common in patients with heart failure with reduced ejection fraction (HFrEF). However, its prognostic relevance in HFrEF, on top of conventional risk factors including natriuretic peptides, is unknown Purpose
Autor:
James P. Daubert, Valentina Kutyifa, Christine Tompkins, Bronislava Polonsky, Wojciech Zareba, Scott McNitt, Arthur J. Moss, Paul J. Wang
Publikováno v:
Journal of Cardiovascular Electrophysiology. 28:94-102
INTRODUCTION Approximately 10-20% of ICD recipients receive inappropriate device therapies. The purpose of this study was to compare the frequency of inappropriate therapies (IT) between men and women enrolled in MADIT II and MADIT-CRT, and assess fo
Publikováno v:
Trends in Cardiovascular Medicine. 26:137-146
Cardiac resynchronization therapy (CRT) has evolved as a Class I treatment indication with Level of Evidence A, in patients with mild heart failure, depressed left ventricular ejection fraction, and wide QRS. In this review article, we will discuss t
Autor:
Ilan Goldenberg, Alon Barsheshet, Wojciech Zareba, Sabu Thomas, Helmut U. Klein, Yitschak Biton, Valentina Kutyifa, David T. Huang, Arthur J. Moss, Scott McNitt
Publikováno v:
Journal of Cardiac Failure. 22:143-149
Cardiac resynchronization with defibrillators (CRT-D) reduces heart failure and mortality compared with defibrillators alone. Whether this applies to all ages is unclear.We assessed the association of age on heart failure and death as a post hoc anal
Autor:
Wojciech Zareba, Valentina Kutyifa, Scott McNitt, Gregory Golovchiner, Arwa Younis, Bronislava Polonsky, Alon Barsheshet, May Goldenberg
Publikováno v:
Journal of the American College of Cardiology. 75:449
We have previously shown that a response score, including 7 baseline clinical and echocardiographic factors, can be used to predict CRT-D benefit among patients enrolled in MADIT-CRT over a median of 2.4 years. We aimed to evaluate the yield of the s